LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
LKFT
78 hedge funds and large institutions have $922M invested in Lakefront Biotherapeutics American Depositary Shares in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.93% more ownership
Funds ownership: 21.76% → 23.69% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
61% less call options, than puts
Call options by funds: $260K | Put options by funds: $675K
Holders
78
Holding in Top 10
3
Calls
$260K
Puts
$675K
Top Buyers
| 1 | +$180M | |
| 2 | +$30.9M | |
| 3 | +$13M | |
| 4 |
Jane Street
New York
|
+$10M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.9M |
Top Sellers
| 1 | -$89.7M | |
| 2 | -$10.3M | |
| 3 | -$8.14M | |
| 4 |
DM
Deerfield Management
New York
|
-$6.08M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.16M |